Cite

    Karissa Johnston et al.. “Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis.” Expert review of pharmacoeconomics & outcomes research, vol. 22, 2022, pp. 155–166. http://access.bl.uk/ark:/81055/vdc_100148638542.0x00002b